Monica A. Slavin

机构：The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Peter Doherty Institute · ORCID：0000-0002-8443-314X

发表论文 561 篇 · 总被引 25549 次 · h-index 75

代表论文

• Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study (2025 · The Lancet Infectious Diseases · 被引 76)
• Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS) (2025 · Clinical Infectious Diseases · 被引 38)
• Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study (2025 · Intensive Care Medicine · 被引 37)
• Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance (2025 · Journal of Infection · 被引 15)
• Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy (2025 · Intensive Care Medicine · 被引 14)
• Influenza Vaccination Strategies in Patients with Hematologic Cancer (2025 · New England Journal of Medicine · 被引 11)